India Pharma API Summit 2026

At a time when India is accelerating its journey toward self-reliance in pharmaceuticals, a Pharma API Summit is both timely and strategically critical. The COVID-19 experience and ongoing global supply-chain disruptions have underscored the risks of high dependence on API imports, particularly from limited geographies. As India seeks to secure its healthcare ecosystem, reduce vulnerabilities, and strengthen domestic manufacturing, a focused summit provides a much-needed platform to align policy intent, industry capability, and investment appetite.

The Pharma API Summit brings together API manufacturers, technology providers, policymakers, investors, and global buyers to address key challenges such as capacity expansion, cost competitiveness, environmental compliance, and access to advanced process technologies. By enabling dialogue on incentives, regulatory reforms, indigenisation strategies, and innovation, the summit helps catalyse actionable collaborations. At this juncture, such a forum plays a pivotal role in accelerating India’s ambition to emerge as a reliable, resilient, and globally competitive API manufacturing hub, while safeguarding national health security. all with the singular objective of building profitable patient centric enterprises.